Olubunmi Ogunrin

1. Introduction The “2018 He Jiankui human genome editing case” exposed loopholes in China’s ethics review system, highlighting the need for improvement. As biomedical research involving human subjects becomes more prevalent, the ethical review process has become cumbersome and complex.

1. Introduction Epilepsy is a treatable noninfectious disease that can affect people at any age (1). A global survey carried out by the WHO showed that 50 million people are affected by epilepsy (2) and 90% of them are found in low-income countries (3). Many studies have shown that epileptic patients significantly experience higher levels of psychiatric and psychological comorbidity (3–6).

Introduction Armenia is a developing country located in Southern Caucasus with a population of 3 million people. In early 2018, the World Bank upgraded Armenia’s status from a “lower middle-income” to an “upper middle-income” nation, with health expenditure per capita reaching 524 USD. Given the epilepsy prevalence rate of 5 per 1,000 person-years (1), the estimated number of people with active epilepsy in the country is 15,000 at any given point.